Nav: Home

Key drug target shown assembling in real-time

May 20, 2019

Over one-third of all FDA-approved drugs act on a specific family of proteins: G-protein coupled receptors (GPCRs). Drugs to treat high blood pressure, asthma, cancer, diabetes and myriad other conditions target GPCRs throughout the body--but a recent study shows what happens next. In results published in Cell, researchers outline the timeline of events, including precisely when and how different parts of a GPCR interacts with its G protein signaling partners. The findings provide new insights into the fundamental mechanisms of drug-induced signaling in cells, including ways to identify the most critical portions of GPCRs for targeting development of novel therapeutics.

"We're able to see--from millisecond to minutes timescales--the detailed sequence of events where a GPCR encounters its downstream signaling partner and catalyzes a change in its structure, providing the basis for understanding its signaling," said corresponding author David Lodowski, PhD, assistant professor in the Department of Nutrition at Case Western Reserve University School of Medicine. "The most exciting part is that we can follow the signaling in a time-resolved manner. We first rapidly mix the activated GPCR and its G-protein signaling partner, and then capture time-resolved details along the natural signaling pathway."

The researchers observed the formation of the GPCR signaling complex using a powerful technique called "radiolytic footprinting" that couples chemical labeling of proteins with mass analysis. In this technique, high intensity X-rays are used to generate highly reactive chemical labels from the water surrounding proteins, enabling a "snapshot" of the protein's regions of interest. This x-ray footprinting technique was pioneered by Mark Chance, PhD, vice dean for research at Case Western Reserve University School of Medicine and a coauthor on the manuscript.

"Our footprinting approach efficiently labels the outside of proteins," Lodowski explained. "If a protein in isolation is labeled on one side, and then in complex is no longer labeled there, we know that's most likely the interaction surface." This approach helped the researchers understand how a GPCR uses its different parts of its surface to engage with the G protein.

Previous studies have shown what GPCRs look like at rest (before activation) and long after they've formed complexes with other proteins (and signaling is over). The in-between steps have been more elusive. Said Lodowski, "We are now moving into the fourth dimension--the temporal dimension--of how these complexes form."

Activated GPCRs form a complex with particular G proteins inside cells that control cell functions. The process transfers information (e.g. the signal) from the GPCR to the signaling partner. The study reveals specifics in this process, called the "G protein cycle." In milliseconds to seconds, GPCRs identify a signal (such as a hormone or drug), reconfigure themselves, recruit specific G proteins inside cells, and activate cellular signaling cascades.

The new analysis technique can identify when a certain portion of a GPCR--individual amino acids, for example--locks in with target amino acids inside a G protein. It thus reveals precise amino acids most central to GPCR function. If applied to GPCRs known to cause disease, such a detailed analysis could potentially uncover new sites for precision drug targeting. "We can use the same techniques to identify precise regions on GPCRs to target therapeutically," Lodowski explained. "If we know site A gets touched before site B in the cycle, then we can design better, more effective drugs."

GPCRs are not easy subjects to study. They are embedded in cell membranes, a natural location that facilitates their ability to transmit information from outside to inside the cell. However, this location complicates their isolation, purification and analysis. Due to these difficulties, structures of GPCRs and their complexes have been exceedingly difficult to solve, with the first structure of a GPCR only determined in 2000. Extensive GPCR structure determination efforts over the past 20 years have enabled the structure determination of a number of GPCRs, including the first GPCR-G protein complex structure in 2012, which earned Brian Kobilka, MD, of Stanford University the Nobel Prize in Chemistry. Kobilka was also a corresponding author on the new Cell publication.

"This work would not have been possible without our world-class team of investigators including collaborators at Stanford, Sungkyunkwan University in Korea, the University of Copenhagen in Denmark, and the scientists and engineers at the Case Center for Synchrotron Biosciences at Brookhaven National Laboratory," Chance said. The Case Center for Synchrotron Biosciences, located at the National Synchrotron Light Source II (NSLS-II) at Brookhaven laboratory, operates the custom footprinting beamline (BM-17) the researchers used in the new study.

Going forward, the researchers plan to use the beamline at NSLS-II to further analyze activation of GPCRs and their complexes. They'll combine their findings with existing GPCR structural data to better understand how GPCRs work. The results could lead to better beta-blockers, chemotherapy drugs, even drugs to treat vision or cognitive deficits.

"GPCRs are critical targets for a variety of new drugs," Lodowski said. "We've had some ideas of how GPCRs and their signaling complexes come together, but not the sequence of events with molecular detail. It's exciting that this novel time resolved approach allows us to extract more meaning from these structures."
This research used Beamline BM-17 (XFP) of the National Synchrotron Light Source II, a U.S. Department of Energy Office of Science User Facility operated by Brookhaven National Laboratory under contract DE-SC0012704. Funding was provided by the National Research Foundation of Korea (NRF-2018R1A2B6001554 and NRF-2012R1A5A2A28671860 to K.Y.C.); the Lundbeck Foundation (to S.G.F.R.); the Danish Medical Research Council (to S.G.F.R.); the Carlsberg Foundation (to S.G.F.R.); the UNIK Center for Synthetic Biology (to S.G.F.R.); the German Academic Exchange Service (to D.H.); the National Institutes of Health (R00EY09718 to D.T.L., P30EB09998 to M.R.C., and R01GM083118 to B.K.K.). The National Science Foundation provided funding to develop and build BM-17 through a MRI grant (DBI-1228549 to M.R.C.). B.K.K. is also a Chan Zuckerberg Biohub investigator.

Du, Y, et al. "Assembly of a GPCR-G Protein Complex." Cell. DOI: 10.1016/j.cell.2019.04.022

For more information about Case Western Reserve University School of Medicine, please visit:

Case Western Reserve University

Related Proteins Articles:

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.
Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.
Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.
Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.
How proteins become embedded in a cell membrane
Many proteins with important biological functions are embedded in a biomembrane in the cells of humans and other living organisms.
Finding the proteins that unpack DNA
A new method allows researchers to systematically identify specialized proteins called 'nuclesome displacing factors' that unpack DNA inside the nucleus of a cell, making the usually dense DNA more accessible for gene expression and other functions.
A brewer's tale of proteins and beer
The transformation of barley grains into beer is an old story, typically starring water, yeast and hops.
New tool for the crystallization of proteins
ETH researchers have developed a new method of crystallizing large membrane proteins in order to determine their structure.
New interaction mechanism of proteins discovered
UZH researchers have discovered a previously unknown way in which proteins interact with one another and cells organize themselves.
When proteins shake hands
Protein nanofibres often have outstanding properties such as a high stability, biodegradability, or antibacterial effect.
More Proteins News and Proteins Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 1: Numbers
In a recent Radiolab group huddle, with coronavirus unraveling around us, the team found themselves grappling with all the numbers connected to COVID-19. Our new found 6 foot bubbles of personal space. Three percent mortality rate (or 1, or 2, or 4). 7,000 cases (now, much much more). So in the wake of that meeting, we reflect on the onslaught of numbers - what they reveal, and what they hide.  Support Radiolab today at